North Tide Capital buys $27,172,500 stake in Halyard Health Inc (HYH)

Halyard Health Inc (HYH) : North Tide Capital scooped up 250,000 additional shares in Halyard Health Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 15, 2016. The investment management firm now holds a total of 750,000 shares of Halyard Health Inc which is valued at $27,172,500.Halyard Health Inc makes up approximately 2.77% of North Tide Capital’s portfolio.

Other Hedge Funds, Including , Qs Investors added HYH to its portfolio by purchasing 8 company shares during the most recent quarter which is valued at $290.Letko Brosseau Associates Inc reduced its stake in HYH by selling 1,910 shares or 2.4% in the most recent quarter. The Hedge Fund company now holds 77,533 shares of HYH which is valued at $2,813,673. Halyard Health Inc makes up approx 0.03% of Letko Brosseau Associates Inc’s portfolio.First Quadrant L Pca reduced its stake in HYH by selling 500 shares or 81.7% in the most recent quarter. The Hedge Fund company now holds 112 shares of HYH which is valued at $3,788.

Halyard Health Inc closed down -0.2 points or -0.55% at $36.25 with 2,86,650 shares getting traded on Thursday. Post opening the session at $36.42, the shares hit an intraday low of $35.793 and an intraday high of $36.55 and the price fluctuated in this range throughout the day.Shares ended Thursday session in Red.

On the company’s financial health, Halyard Health Inc reported $0.45 EPS for the quarter, beating the analyst consensus estimate by $ 0.09 according to the earnings call on Aug 3, 2016. Analyst had a consensus of $0.36. The company had revenue of $400.00 million for the quarter, compared to analysts expectations of $382.39 million. The company’s revenue was up 2.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.52 EPS.

Many Wall Street Analysts have commented on Halyard Health Inc. Company shares were Reiterated by Deutsche Bank on Aug 10, 2016 to “Buy”, Firm has raised the Price Target to $ 41 from a previous price target of $36 .Company shares were Reiterated by Stifel on Aug 4, 2016 to “Buy”, Firm has raised the Price Target to $ 38 from a previous price target of $37 .Company shares were Reiterated by Stifel on Jun 14, 2016 to “Buy”, Firm has raised the Price Target to $ 37 from a previous price target of $32 .

Halyard Health Inc. seeks to advance health and healthcare by preventing infection eliminating pain and speeding recovery. The Company has two business segments: Surgical and Infection Prevention (S&IP) and Medical Devices. The Company’s S&IP business provides healthcare supplies and solutions that target the prevention of healthcare associated infections. S&IP’s product portfolio includes sterilization wrap surgical drapes and gowns facial protection protective apparel and medical exam gloves. Medical Devices segment provides a portfolio of product offerings including post-operative pain management solutions minimally invasive interventional (or chronic) pain therapies closed airway suction systems and enteral feeding tubes focused on pain management and respiratory and digestive health.

Leave a Reply

Halyard Health Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Halyard Health Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.